Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NAD O.K. with ads comparing Aleve to Advil

This article was originally published in The Tan Sheet

Executive Summary

Bayer Healthcare's ads comparing Aleve to Wyeth Consumer Healthcare's Advil meet the National Advertising Division's approval. According to a Sept. 9 report, NAD reviewed the ads after Wyeth complained claims that Aleve is "the best value" and "Just 2 Aleve = 4 Advil" are implied superiority claims. NAD disagreed, finding the pill-count comparison is based appropriately on FDA-approved labels for Aleve and Advil. Wyeth also complained Bayer claims Aleve can "stop pain all day" and provide "all day pain-free movement" are not but should be supported by studies. NAD disagreed, noting "no reasonable consumer would expect total pain relief.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103390

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel